None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient with gastroesophageal reflux disease, adult males and females aged 19 years or older who have been prescribed proton pump inhibitors for 90 days or more during the same period of follow-up observation for the past 12 months or longer as of the date of written consent 2. Patient whose symptoms are recorded for typical symptoms of gastroesophageal reflux disease (heartburn or acid reflux) in medical records for the same period 3. Patient who can write a questionnaire 4. Patient who had voluntarily decided participation, and provided written consent
Exclusion criteria
Exclusion criteria: 1.Patient taking proton pump inhibitors for diseases other than gastroesophageal reflux disease (peptic ulcer, peptic ulcer prevention, eosinophilic esophagitis, functional dyspepsia, etc.) 2.Patient with primary or secondary esophageal motility disorder 3.Patient with surgery related to esophagus, stomach, duodenum 4.Patient with a history of untreated malignant tumors 5.Patient who has significant disease with liver, kidney, cardiac, respiratory, endocrine, central nervous system 6.Patient with a history of drug or alcohol abuse (within 1 year)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall patient's satisfaction according to each prescription pattern for the maintenance treatment of proton pump inhibitors at the actual clinical field | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient's satisfaction with the degree of symptom control of the current medication pattern;Patient's satisfaction with the convenience of taking the current medication pattern;The patient's preferred maintenance treatment pattern of proton pump inhibitors;Side effects associated with maintenance treatment of proton pump inhibitors | — |
Countries
Korea, Republic of
Contacts
Yonsei University Yongin Severance Hospital